Regulations.gov document
Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C…
Other · FDA-2005-D-0140 · posted Dec 28, 2017
Key facts
| Document ID | FDA-2005-D-0140-0010 |
|---|---|
| Title | Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry: Guidance for Industry |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2005-D-0140 |
| Posted | Dec 28, 2017 |
| Comment period opens | Dec 28, 2017 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: